Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel.
暂无分享，去创建一个
M. Leblanc | C. Tangen | N. Agarwal | Jingsong Zhang | I. Thompson | A. Goldkorn | E. Gertz | D. Quinn | N. Vogelzang | M. Hussain | Shilpa Gupta | P. Twardowski | M. Parikh | P. Lara | E. Mayerson | M. van Loan